Orofar Ultra (Flurbiprofen)

Flurbiprofen, the active ingredient in Orofar Ultra, is a NSAID presented as an oral tablet for oral use. It is used to relieve pain and inflammation in conditions such as arthritis, postoperative discomfort, and dental pain, primarily in adult patients.

GNH USA supplies Orofar Ultra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Flurbiprofen is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes.

Rheumatoid arthritis: alleviates joint pain, swelling and stiffness Osteoarthritis: improves mobility and reduces chronic joint discomfort Postoperative pain: provides short‑term analgesia after surgical procedures Dental pain: eases pain and inflammation following dental extractions or procedures Dysmenorrhea: lessens menstrual cramp pain

Flurbiprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dyspepsia or stomach upset - Nausea and occasional vomiting - Headache or mild dizziness - Transient rash or itching - Mild elevation of liver enzymes - Fluid retention or mild edema

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Severe renal impairment or acute kidney injury - Hepatotoxicity with marked liver enzyme rise - Anaphylactic or severe allergic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Cardiovascular events such as myocardial infarction

When prescribing Flurbiprofen, clinicians should consider several safety measures.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use Monitor renal function: especially in elderly patients or those with pre‑existing kidney disease Avoid in patients with known hypersensitivity to flurbiprofen or other NSAIDs Use caution with anticoagulants: increased risk of bleeding Avoid in late pregnancy: potential fetal cardiovascular complications Store at room temperature: keep in the original pack, protect from moisture and direct sunlight

Flurbiprofen can interact with a variety of medicines; awareness of the interaction level guides management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk - Other NSAIDs or aspirin: additive gastrointestinal toxicity - Corticosteroids: increased ulceration potential - Lithium: elevated lithium serum concentrations - Methotrexate: reduced clearance leading to toxicity

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function - Diuretics: risk of renal impairment and electrolyte imbalance - Selective serotonin reuptake inhibitors: modest increase in bleeding tendency - Beta‑blockers: may blunt antihypertensive effect - Antidiabetic agents: potential alteration of glucose control